Endacea Inc Hours

We collected information about Endacea Inc Hours for you. Follow the liks to find out everything about Endacea Inc Hours.


Contact ENDACEA | ENDACEA

    http://endacea0.04a276d.netsolhost.com/contact/
    Endacea, Inc. PO Box 13169 Research Triangle Park, NC 27709. Hours of Operation; Monday-Friday, 9 a.m.-5 p.m.

Endacea Home Page

    http://endacea.net/
    Endacea, Inc. (RTP, NC), an emerging biopharmaceutical company, is developing a series of proprietary A 1 adenosine receptor (AR) antagonists as drug candidates for a number of medical indications: 1) inflammation, including sepsis and asthma; and 2) renal impairment. Endacea is advancing the Company's lead compound A 1 AR antagonist, L-97-1 ...

Endacea, Inc. - Contact Us

    http://www.endacea.com/contact.html
    Endacea, Inc. - Contact Us Management: Constance Neely Wilson, M.D. President and Chief Executive Officer Chief Scientific Officer 919-406-1888 x1400. Email: cwilson @ endacea.com : Mailing Address: Endacea, Inc. PO Box 13169 Research Triangle Park, NC 27709-2076. Shipping Address: ...

Endacea-Technology 2 Davis Dr, Durham, NC 27709 - …

    https://www.yellowpages.com/durham-nc/mip/endacea-technology-459291736
    Get reviews, hours, directions, coupons and more for Endacea-Technology at 2 Davis Dr, Durham, NC 27709. Search for other Pharmaceutical Products-Wholesale & …

Endacea, Inc | Research Triangle Park

    https://www.rtp.org/company/endacea-inc/
    Endacea, Inc., an emerging biopharmaceutical company, is developing a series of proprietary A1 adenosine receptor (AR) antagonists as drug candidates for a number of medical indications, including: 1) inflammation, including sepsis and asthma; and 2) renal impairment. Endacea is advancing the company’s lead compound A1 AR antagonist, L-97-1 ...

Endacea, Inc. - What's New

    http://www.endacea.com/whats_new.html
    Endacea Diagnostics, Inc. formed to advance EndaTox IVD, sepsis diagnostic: In February 2012, Endacea formed a subsidiary corporation, Endacea Diagnostics, Inc. (Endacea Dx) to complete the development and commercialization of the Company's assay to measure endotoxin (lipopolysaccharide, LPS) in both non-biological and biological samples.

Endacea, Inc. - About Us

    http://www.endacea.com/about.html
    Endacea, Inc. - MORE About Us. In addition to sepsis and renal impairment, Endacea believes that other indications for Endacea's proprietary A 1 AR antagonists include allergic rhinitis, asthma, and chronic obstructive pulmonary disease. Endacea is a development stage biopharmaceutical company with a proprietary A1 adenosine receptor based ...

Endacea, Inc. - Science

    http://www.endacea.com/science.html
    Endacea is a development stage biopharmaceutical company with a proprietary A1 adenosine receptor based technology platform for the treatment of asthma, ischemia-reperfusion organ injury, and Gram-negative septicemia (endotoxemia), as well as an assay for endotoxin.

Endacea, Inc. - Management Summary Biographies

    http://www.endacea.com/leadership.html
    Endacea, Inc. - LEADERSHIP. Constance Neely Wilson, M.D. - President, Chief Executive Officer, Chief Scientific Officer; Founder and Director. Dr. Wilson is the inventor of Endacea's A1 adenosine receptor-based technologies. She is a Board Certified Anesthesiologist and Critical Care physician scientist with strong expertise in cardiopulmonary ...

Endacea, Inc. - Product Pipeline

    http://www.endacea.com/pipeline.html
    In February 2012, Endacea formed a subsidiary corporation, Endacea Diagnostics, Inc. (Endacea Dx) to complete the development and commercialization of the Company's assay to measure endotoxin (lipopolysaccharide, LPS) in both non-biological and biological samples.

Searching for Endacea Inc Hours?

You can just click the links above. The info is collected for you.

Related Hours Info